Purinergic receptors

Polish Journal of Pharmacology

Volumn 48, Issue 5, 1996, Pages 457-465

  Malec, Danuta ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

nucleosides; nucleotides; purinergic receptors; review

Indexed keywords

2 CHLOROADENOSINE; 6 N CYCLOPENTYLADENOSINE; 8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 8 CYCLOPENTYLTHEOPHYLLINE; 8 PHENYLTHEOPHYLLINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE AMINE CONGENER; ADENOSINE RECEPTOR; CAFFEINE; CYCLIC AMP; CYCLOHEXYLADENOSINE; DIADENOSINE TETRAPHOSPHATE; GUANINE NUCLEOTIDE BINDING PROTEIN; NUCLEOSIDE; NUCLEOTIDE; PHENYLISOPROPYLADENOSINE; PURINE P2 RECEPTOR; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; PURINE RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE; THEOPHYLLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BRAIN; CLASSIFICATION; HEART; HUMAN; NONHUMAN; PHYSIOLOGY; RECEPTOR BINDING; REVIEW; SMOOTH MUSCLE; TISSUE DISTRIBUTION;

ANIMALS; HUMANS; RECEPTORS, PURINERGIC; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2;

EID: 0030464825     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. Allgaier C., Hertting G., Kugelgen O. V.: The adenosine receptor-mediated inhibition of noradrenaline release possibly involves a N-protein and is increased by 2-autoreceptor blockade. Brit. J. Pharmacol., 1987, 90, 403-412.
2. Andine P., Rudolphi K. A., Fredholm B. B., Hagberg H.: Effects of propentophylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischemia. Brit. J. Pharmacol., 1990, 100, 814-818.
3. Barraco R. A.: Behavioural actions of adenosine and related substances. In: Adenosine and Adenine Nucleotides as Regulators of Cellular Function. Ed. Phillis J. W., CRC Press, Boca Raton, 1991, 339-366.
4. Bean B. P.: Pharmacology and electrophysiology of ATP-activated ion channels. Trends Pharmacol. Sci., 1992, 13, 87-90.
5. Benham C. D.: ATP-gated channels in vascular smooth muscle cells. Ann. NY Acad. Sci., 1990, 603, 275-286.
6. Berne R. M., Knabb R. M, Ely S. W., Rubio R.: Adenosine in the local regulation of blood flow: a brief overview. Fed. Proc., 1983, 42, 3136-3142.
7. Boyer J. L., Downes C. P., Harden T. K.: Kinetics of activation of phospholipase C by P2y purinergic receptor agonists and guanine nucleotides. J. Biol. Chem., 1989, 264, 884-890.
8. Brown C. M., Burnstock G.: The structural conformation of the polyphosphate chain of the ATP molecule is critical for its promotion of prostaglandin biosynthesis. Eur. J. Pharmacol., 1981, 69, 81-86.
9. Bruns R. F.: Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists. Can. J. Physiol. Pharmacol., 1980, 58, 673-691.
10. Bruns R. F.: Role of adenosine in energy supply/demand balance. Nucleos. Nucleot., 1991, 10, 931-934.
11. 3H]-NECA in rat striatal membranes. Mol. Pharmacol. 1986, 29, 331-346.
12. Burnstock G.: A basis for distinguishing two types of purinergic receptors. In: Cell Membrane Receptors for Drugs and Hormones. Eds. Bolis L., Straub R. N., Raven Press, New York, 1978, 107-118.
13. Bumstock G., Kennedy C.: Is there a basis for distinguishing two types of P2-purinoceptor? Gen. Pharmacol., 1985, 17,433-440.
14. Busse R., Mulsch A.: Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett., 1990, 265, 133-136.
15. Cockroft S., Stutchfield J.: ATP stimulates sceretion in human neutrophils and HL60 cells via a pertussis toxin-sensitive guanine nucleotide-binding protein coupled to phospholipase C. FEBS Lett., 1989, 245, 25-29.
16. Cockcroft S., Stutchfield J.: The receptors for ATP and fMetLeuPhe are independently coupled to phospholipases C and A2 via G-protein(s). Biochem. J., 1989, 263, 715-723.
17. Colman R. W., Figures R. W.: Characteristic of an ADP receptor mediating platelet activation. Mol. Cell. Biochem., 1984, 59, 101-111.
18. Coradetti R., Loconte G., Moroni F., Passani N. B., Pepeu G.: Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur. J. PharmacoL, 1984, 104, 19-26.
19. 3H] - CV 1808) labels a novel adenosine receptor in rat brain. J. PharmacoL Exp. Ther., 1992, 263, 552-561.
20. Cusack N. J., Hourani S. M. O.: Adenosine 5'-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors. Brit. J. Pharmacol., 1982, 76, 221-227.
21. Daly J. W., Butts-Lamb P., Padgett W.: Subclasses of adenosine receptors in the central nervous system. Interaction with caffeine and related methylxanthines. Cell. Mol. Neurobiol., 1983, 3, 69-80.
22. Dalziel H. H., Westfall D. P.: Receptors for adenine nucleotides and nucleosides: subclassification, distribution and molecular characterization. Pharmacol. Rev., 1994, 46, 449-466.
23. Daval J. L., Nehlig A., Nicolas F.: Physiological and pharmacological properties of adenosine: therapeutic implications. Life Sci., 1991, 49, 1435-1453.
24. Deckert J., Gleiter C. H.: Adenosine -an endogenous neuroprotective metabolite and neuromodulator. J. Neural Transm., 1994, Suppl. 43, 23-31.
25. Deckert J., Jorgensen M. B.: Evidence for pre- and postsynaptic localization of adenosine Al receptors in the CA1 region of rat hippocampus: a quantitative autoradiographic study. Brain Res., 1988, 446, 161-164.
26. Detwiler T. C., Feinman R. D.: Kinetics of the trombin-induced release of adenosine triphosphate by platelets. Comparison with release of calcium. Biochemistry, 1973, 12, 2462-2468.
27. Dowdall M. J., Boyne A. F., Whittaker V. P.: Adenosine triphosphate - a constituent of cholinergic synaptic vesicles. Biochem. J., 1974, 140, 1-12.
28. Dragunow M., Raull R. L. M.: Neuroprotective effects of adenosine. Trends Pharmacol. Sci., 1988, 9, 193-194.
29. Drury A. N., Szent-Gyorgi A.: The physiological activity of adenine compounds with special reference to their actions upon the mammalian heart J. Physiol. - London, 1929, 68, 213-237.
30. Edwards F. A., Gibb A. J.: ATP - a fast neurotransmitter. FEBS Lett., 1993, 325, 86-89.
31. Erfurth A.: Adenosine and neuropsychiatric disorders. CNS Drugs, 1994, 2, 184-190.
32. 1 adenosine receptors decreases the release of serotonin in the rabbit hippocampus, but not in the caudate nucleus. Naunyn-Schmied, Arch. Pharmacol., 1988, 338, 664-670.
33. Forsberg R J., Feuerstein G., Shohami E., Pollard H. B.: Adenosine triphosphate stimulates inositol phospholipid metabolism and prostacyclin formation in adrenal medullary endothelial cells by means of P2-purinergic receptors. Proc. Nat. Acad. Sci. USA, 1987, 84, 5630-5634.
34. Fortes P. A. G., Ellory J. C., Lew V. L.: Suramin: a potent ATPase inhibitor acts on the inside of surface the sodium pump. Biochem. Biophys. Acta, 1973, 318, 262-272.
35. Fozard J. R., Carruthers A. M.: Adenosine A3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat. Brit. J. Pharmacol., 1993, 109, 3-5.
36. Fozard J. R., Hannon J. P.: BW-A522 blocks adenosine A3 receptor-mediated hypotensive responses in the rat Eur. J. Pharmacol., 1994, 252, R5-6.
37. Fredholm B. B: Adenosine, adenosine receptors and the action of caffeine. Pharmacol. Toxicol., 1995, 76, 93-101.
38. Fredholm B. B., Abbracchio M. P., Burnstock G., Daly J. W., Harden T. K., Jacobson K. A., Leff P., Williams M.: Nomenclature and classification of purinoceptors. Pharmacol. Rev., 1994, 46, 143-156.
39. Fredholm B. B, Hedquist P.: Modulation of neurotransmission by purine nucleotides and nucleosides. Biochem. Pharmacol., 1980, 29, 1635-1643.
40. Fried G., Lagercrantz H., Hökfelt T.: Improved isolation of small noradrenergic vesicles from rat seminal ducts following castration. A density gradient centrifugation and morphological study. Neuroscience, 1978, 3, 1271-1291.
41. Gilbertsen R. B.: Adenosine and adenosine receptors in immune function. Agent Action., 1987, 22, 91-98.
42. 3H]-cyclohexyladenosine. J. Neurosci., 1982, 2, 1230-1241.
43. Gordon J. L.: Extracellular ATP: effects, sources and fate. Biochem. J., 1986, 233, 309-319.
44. Gurden M. F., Coates J., Ellis F., Evans B., Foster M., Homby E., Kennedy I., Martin D. P., Strong P., Vardey C. J., Wheeldon A.: Functional characterization of three adenosine receptor types. Brit. J Pharmaco., 1993, 109, 693-698.
45. Hagberg H., Andersson P., Lacarewicz J., Jacobson I., Butcher S., Sanberg M.: Extracellular adenosine, inosine, hypoxanthine and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J. Neurochem., 1987, 49, 227-231.
46. Harms H. H., Wardeh G., Mulder A. H.: Effect of adenosine on depolarization-induced release of various radiolabelled neurotransmitters from slices of rat corpus striatum. Neuropharmacology, 1979, 18, 577-580.
47. Hoyle C. H. V., Knight G. R., Burnstock G.: Suramin antagonizes responses to P2x-purinoceptor agonists and purinergic nerve stimulation in the guinea pig urinary bladder and taenia coli. Brit. J. Pharmacol, 1990, 98, 617-621.
48. Iannone M. A., Zimmerman T. P., Reynolds-Vaughan R., Wolberg G.: Effects of adenosine on human neurotrophil function and cyclic AMP content. In: Topics and Perspectives in Adenosine Research. Eds. Gerlach E., Becker B. F., Springer-Verlag, Berlin, 1987, 286-298.
49. Jacobson K. A., Van Galen P. J. M., Ji X.-D., Ramkumar V., Olah M. E., Stiles G. L.: Molecular characterization of Al and A2a adenosine receptors. Drug Develop. Res., 1993, 28, 226-231.
50. 3H]-CGS 21680, Eur. J. Pharmacol., 1989, 168, 243-246.
51. Jonzon B., Fredholm B. B.: Release of purines, noradrenaline and GABA from rat hippocampal slices by field stimulation. J. Neurochem., 1985, 44, 217-224.
52. Keppens S., Vandekerckhove A., De Wulf H.: Extracellular ATP and UTP exert similar effects on rat isolated hepatocytes. Brit. J. Pharmacol., 1992, 105, 475-479.
53. Linden J.: Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol. Sci., 1994, 15, 298-306.
54. Lloyd H. G. E., Schrader J.: The importance of the transmethylation pathway in the production of adenosine. In: Topics and Perspectives in Adenosine Research. Eds. Gerlach E., Becker B. F., SpringerVarlag, Berlin, 1987, 199-208.
55. Londos C., Cooper D. M. F., Wolff J.: Subclasses of external adenosine receptors. Proc. Nat. Acad. Sci. USA, 1980, 77, 2551-2554.
56. Londos C., Wolff T., Cooper D. M. F.: Adenosine receptors and adenylate cyclase interactions. In: Regulatory Function of Adenosine. Eds. Berne R. M., Hall T. W., Rubio R., Martinus Nijhoff Publishers, The Hague, 1983, 17-32.
57. Lustig K. D., Erb L., Landis D. M., Hicks-Taylor C. S., Zhang X., Sportiello M. G., Weisman G. A.: Mechanism by which extracellular ATP and UTP stimulate the release of prostacyclin from bovine pulmonary artery endothelial cell. Biochim. Biophys. Acta, 1992, 1134, 61-72.
58. Meghji P.: Storage, release, uptake, and inactivation of purines. Drug Develop. Res., 1993, 28, 214-219.
59. Meyerhof W., Muller-Brechlin R., Richter D.: Molecular cloning of a novel putative G-protein coupled receptor expressed during rat spermiogenesis. FEBS Lett., 1991, 284, 155-160.
60. Munshi R., Pang J. H., Sternweis P. C., Linden J.: Al adenosine receptors of bovine brain couple to guanine nucleotide -binding proteins Gil, Gi2 and GO. J. Biol. Chem., 1991, 22285-22289.
61. Newby A. C.: Adenosine as a retaliatory metabolite. Trends Biol. Sci., 1984, 9, 42-44.
62. Newby A. C., Worku Y., Meghji P.: Critical evaluation of the role of ecto- and cytosolic 5'-nucleotidase in adenosine formation. In: Topics and Perspectives in Adenosine Research. Eds. Gerlach E., Becker B. F., Springer-Verlag, Berlin, 1987, 155-169.
63. O'Connor S. E.: Recent developments in the classification and functional significance of receptors for ATP and UTP, evidence for nucleotide receptors. Life Sci., 1992, 50, 1657-1664.
64. O'Connor S. E., Dainty I A., Leff P.: Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol. Sci., 1991, 12, 137-141.
65. Ohisalo J. J., Strouffer J. E.: Adenosine, thyroid status and regulation of lipolysis. Biochem. J., 1979, 178, 249-251.
66. Olah M. E., Stiles G. L.: Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol., 1995, 35, 581-606.
67. Osswald H.: Adenosine and renal function. In: Regulatory Function of Adenosine. Eds. Berne R. M., Rall T. W., Rubio R., Martinus Nijhoff Publishers, Boston, 1983, 399-415.
68. Pearson J. D.: Ectonucleotidases: measurement of activities and use of inhibitors. In: Methods in Pharmacology, vol. 6. Methods Used in Adenosine Research. Ed. Paton D. M., Plenum Press, New York, 1985, 83-107.
69. Phillis J. W.: Behavioral and other actions of adenosine in the central nervous system. In: Neurotransmitters and Cortical Function. From Molecules to Mind. Eds. Avoli M., Reader T. A., Dykes R. W., Gloor P., Plenum Press, New York, 1988, 403-414.
70. Phillis J. W., Barraco R. A.: Adenosine, adenylate cyclase and transmitter release. In: Advances in Cyclic Nucleotide and Protein Phosphorylation Research, vol. 19, Eds. Greengard P., Robinson G. A., Raven Press, New York, 1985, 243-257.
71. Phillis J. W., Wu P. H.: The role of adenosine and its nucleotides in central synaptic transmission. Prog. Neurobiol., 1981, 16, 187-239.
72. Pintor J., Miras-Portugal M T.: Diadenosine polyphosphates - ApnA - as new neurotransmitters. Drug Develop. Res., 1993, 28, 259-262.
73. Pintor J., Miras-Portugal M. T.: P2 purinergic receptors for diadenosine polyphosphates in the nervous system. Gen. Pharmacol. 1995, 26, 229-235.
74. Polmar S. H., Birch R. E., Mandle R., Rudolph S. A.: Adenosine and cyclic nucleotides in modulation of immune responses. In: Regulatory Function of Adenosine. Eds. Berne R. M., Rall T. W., Rubio R., Matrinus Nijhoff Publishers, Boston, 1983, 249-259.
75. Proctor K. G.: Possible role for adenosine in local regulation of absorptive hyperania in rat intestine. Circ. Res., 1986, 59, 474-481.
76. Ramkumar V., Stiles G. L., Beaven M. A., Ali H.: The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem., 1993, 268, 16667-16690.
77. Ribeiro J. A.: Purinergic regulation of transmitter release. In: Adenosine and Adenine Nucleotides as Regulators of Cellular Function. Ed. Phillis J. W., CRC Press, Boca Raton, 1991, 155-167.
78. Ribeiro J. A., Sebastiano A. M.: Adenosine receptors and calcium: basis for proposing a third (A3) adenosine receptor. Prog. Neurobiol., 1986, 26, 179-209.
79. Rubio R., Bencherif M., Berne R. M.: Inositol phospholipid metabolism during and following synaptic activation: role of adenosine. J. Neurochem., 1989, 52, 797-806.
80. Rudolphi K. A., Schubert P., Parkinson F. E., Fredholm B. B.: Neuroprotective role of adenosine in cerebral ischemia. Trends Pharmacol. Sci., 1992, 13, 439-445.
81. Salvatore C. A., Jacobson M. A., Taylor H. E., Linden J., Johnson R. G.: Molecular cloning and characterization of the human A3 adenosine receptor. Proc. Nat. Acad. Sci. USA, 1993, 90, 10365-10369.
82. Sawynok J., Jhamandas K. H.: Inhibition of acetylcholine release from cholinergic nerves by adenosine, adenine nucleotides and morphine: antagonism by theophylline. J. Pharmacol. Exp. Ther., 1976, 197, 379-390.
83. Snyder S. H.: Adenosine as a neuromodulator. Annu. Rev. Neurosci., 1985, 8, 103-124.
84. Uleand P. M.: Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase. Pharmacol. Rev., 1982, 34, 223-253.
85. Van Calker D., Muller M., Hamprecht B.: Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem., 1979, 33, 999-1005.
86. Watt A. H., Routledge P. A.: Adenosine stimulates respiration in man. Brit. J. Clin. Pharmacol., 1985, 20, 503-506.
87. White T. D.: Role of adenine compounds in autonomic neurotransmission. Pharmacol. Ther., 1988, 38, 129-168.
88. + uptake: inhibition of fluxes by suramin. Arch. Biochem. Biophys. 1993, 305, 54-64.
89. Williams M.: Adenosine - a selective neuromodulator in the CNS? Trends Neurosci., 1984, 7, 164-168.
90. Wills E. D., Wormall A.: Studies on suramin. 9. The action of the drug on some enzymes. Biochem. J., 1950, 47, 158-170.
91. Winkler H., Carmichael S. W.: The chromaffin granule. In: The Secretory Granule. Eds. Poisner A. M, Trifaro J. M., Elsevier, Amsterdam, 1982, 3-79.
92. Winn H. R., Rubio R., Berne R. M.: Brain adenosine concentration during hypoxia in rats. Amer. J. Physiol. 1981, 241, H235-H242.
93. Wood P. L., Kim H. S., Boyar W. C, Hutchison A.: Inhibition of nigrostriatal release of dopamine in the rat by adenosine receptor agonists: Al receptor mediation. Neuropharmacology, 1989, 28, 21-25.
94. 6-(phenylisopropyl) adenosine and hypothyroidism on the responsiveness of rat brown adipocytes to noradrenaline. Biochem. J., 1987, 238, 395-403.
95. Yoon K. W., Rothman S. M.: Adenosine inhibits excitatory but not inhibitory synaptic transmission in the hippocampus. J. Neurosci., 1991, 11, 1375-1380.
96. Zhou Q. Y., Li C., Olah M. E., Johnson R. A., Stiles G. L., Clivelli O.: Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc. Nat. Acad. Sci. USA, 1992, 89, 7432-7436.